10.07.2015 Views

220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S

220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S

220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

16biolent; FDA: “bioequivalent drug products means pharmaceuticalequivalents or pharmaceutical alternatives whose rate andextent <strong>of</strong> absorption do not show a significant difference whenadministered at the same molar dose <strong>of</strong> the therapeutic moiety undersimilar experimental conditions, either single dose or multipledose”; → see also drug comparability study, biologic equivalent,pharmaceutical equivalent, rule 80/125, therapeuticequivalent.bioinformatics The discipline encompassing the development andutilization <strong>of</strong> computational facilities to store, analyze and interpretbiological data.biologic equivalent Dosage form that results in similar bioavailabilityregardless <strong>of</strong> the pharmaceutical formulation; → seealso essentially similar product, pharmaceutical equivalent,therapeutic equivalent.biological medicinal products Products such as vaccines, serums,toxins, allergen products and medicinal products derived fromhuman blood or plasma; → see also biopharmaceutical, establishmentlicence application.biological products Clinical trials with blood or biological productsas well as their registration are subject to special regulations in orderto assure absence <strong>of</strong> infectious contaminants (e.g. mandatoryscreening <strong>of</strong> blood donors).biological rhythm → see chronotherapy.biomarker Def (NIH): “characteristic that is objectively measuredand evaluated as an indicator <strong>of</strong> biologic processes, pathogenicprocesses or pharmacological response to a therapeutic intervention”;→ see also surrogate.biopharmaceutical Therapeutic product involving biotechnology,e.g. genetic engineering; product <strong>of</strong> biotechnological origin suchas antisense, genetic engineering, transgenics, involving manipulation<strong>of</strong> living organisms; → see also biological medicinalproduct, biotechnology.biorepository → see biobank.biotechnology (Biotech) Development <strong>of</strong> products by a biologicalprocess. Production may be carried out by using intact organisms,such as yeasts and bacteria, or by using natural substances (e.g. enzymes)from organisms; techniques involving manipulation <strong>of</strong> livingorganisms or substances made by living organisms, particularlyat the molecular genetic level; according to the U.S. Office <strong>of</strong> Scienceand Technology Policy, the term covers also “recently developedand newly emerging genetic manipulation techniques, such as recombinantDNA (rDNA), recombinant RNA (rRNA), and cell fusion,that are sometimes referred to as genetic engineering”; → see also

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!